Melanoma Clinical Trials in Linyi, Shandong
2 recruitingLinyi, Shandong, China
Showing 1–2 of 2 trials
Recruiting
Phase 1
A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multiple Resected Solid Tumors
MelanomaNon-small Cell Lung CancerRenal Cell Carcinoma
Shanghai Henlius Biotech174 enrolled69 locationsNCT07160335
Recruiting
Early Phase 1
A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Advanced Solid Tumors
Breast CancerSarcomaLung Cancer+7 more
Shanghai Yunying Medical Technology20 enrolled1 locationNCT05961111